Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for disordered simple endometrial hyperplasia
IRCT20120922010901N10Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in endometrial hyperplasia (EH), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Change in endometrial histology. Started Feb 2023; status: completed.
02
Drugs
melatonin
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on IRCT20120922010901N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120922010901N10.